Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Inventory Average (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Inventory Average for 15 consecutive years, with $17.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average fell 44.72% to $17.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $17.5 million, a 44.72% decrease, with the full-year FY2025 number at $21.3 million, down 11.69% from a year prior.
  • Inventory Average was $17.5 million for Q4 2025 at Anika Therapeutics, up from $16.6 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $50.4 million in Q2 2024 to a low of $16.6 million in Q3 2025.
  • A 5-year average of $35.4 million and a median of $36.6 million in 2022 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: surged 37.42% in 2021, then tumbled 63.55% in 2025.
  • Anika Therapeutics' Inventory Average stood at $35.5 million in 2021, then increased by 8.41% to $38.5 million in 2022, then dropped by 11.49% to $34.1 million in 2023, then fell by 6.92% to $31.7 million in 2024, then crashed by 44.72% to $17.5 million in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Inventory Average are $17.5 million (Q4 2025), $16.6 million (Q3 2025), and $19.1 million (Q2 2025).